Stabilized recombinant trefoil factor 2 (TFF2-CTP) enhances anti-tumor activity of PD-1 blockade in mouse models of colorectal cancer

被引：0

作者：

Kim, Woosook ^{[1
]}

Fu, Na ^{[1
]}

Duddempudi, Phaneendra ^{[2
]}

Dubeykovskaya, Zinaida ^{[3
]}

Almo, Steven ^{[2
]}

Guha, Chandan ^{[2
]}

Lederman, Seth ^{[4
]}

Wang, Timothy ^{[1
]}

机构：

[1] Columbia Univ, Med Ctr, New York, NY USA

[2] Albert Einstein Coll Med, New York, NY USA

[3] NYU, New York, NY USA

[4] Tonix Pharmaceut Inc, New York, NY USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-6640

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

6640

引用

页数：2

共 50 条

[31] Cooperative anti-tumor effect of soluble NKG2D ligand MIC neutralization and PD-1 pathway blockade
Basher, Fahmin
Wu, Jennifer
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
[32] CCR2 Blockade Enhances Anti-tumor Immune Responses in Patients with Pancreatic Cancer
Sanford, D.
Belt, B.
Panni, R.
Nywening, T.
Wang-Gillam, A.
Goedegebuure, P.
Linehan, D.
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S39 - S39
[33] PD-1 regulates the anti-tumor immune function of macrophages through JAK2-STAT3 signaling pathway in colorectal cancer tumor microenvironment
Han Jiang
Jingjing Pang
Tengyue Li
Atitso Akofala
Xiaoxi Zhou
Changhua Yi
Shangwei Ning
Xu Gao
Yu Qiao
Jiayuan Kou
Journal of Translational Medicine, 23 (1)
[34] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Chen, Jian
Zhu, Tianchuan
Jiang, Guanmin
Zeng, Qi
Li, Zhijian
Huang, Xi
MOLECULAR CANCER, 2023, 22 (01)
[35] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Jian Chen
Tianchuan Zhu
Guanmin Jiang
Qi Zeng
Zhijian Li
Xi Huang
Molecular Cancer, 22
[36] IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer
Somri-Gannam, Lina
Meisel-Sharon, Shilhav
Hantisteanu, Shay
Bar-Noy, Tomer
Sigal, Emiliya
Groisman, Gabriel
Hallak, Mordechai
Werner, Haim
Bruchim, Ilan
FRONTIERS IN ONCOLOGY, 2024, 14
[37] PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
Parekh, Vrajesh V.
Lalani, Saif
Kim, Sungjune
Halder, Ramesh
Azuma, Miyuki
Yagita, Hideo
Kumar, Vipin
Wu, Lan
Van Kaer, Luc
JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 2816 - 2826
[38] Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
Lewis, Katherine E.
Selby, Mark J.
Masters, Gregg
Valle, Jose
Dito, Gennaro
Curtis, Wendy R.
Garcia, Richard
Mink, Kathy A.
Waggie, Kimberly S.
Holdren, Matthew S.
Grosso, Joseph F.
Korman, Alan J.
Jure-Kunkel, Maria
Dillon, Stacey R.
ONCOIMMUNOLOGY, 2018, 7 (01):
[39] Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer
WANG Ting
WU Linguangjin
WANG Shuyun
SHI Xiaolan
LIU Hui
DENG Wanli
Chinese Journal of Natural Medicines, 2023, 21 (05) : 333 - 345
[40] NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model
Sola, Caroline
Arnoux, Thomas
Chanuc, Fabien
Fuseri, Nicolas
Rossi, Benjamin
Gauthier, Laurent
Leget, Corinne
Bonnafous, Cecile
Wagtmann, Nicolai
Morel, Yannis
Andre, Pascale
CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →